Search

Your search keyword '"Lade S."' showing total 200 results

Search Constraints

Start Over You searched for: Author "Lade S." Remove constraint Author: "Lade S."
200 results on '"Lade S."'

Search Results

2. CD274 structural variants for guiding treatment with PD-1 blockade in a patient with relapsed/refractory chronic active EBV transformed to NK lymphoma.

3. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

4. Prognostic gene expression signature for high-grade serous ovarian cancer

5. A just world on a safe planet: a Lancet Planetary Health–Earth Commission report on Earth-system boundaries, translations, and transformations

6. Living within the safe and just Earth system boundaries for blue water

7. Applying earth system justice to phase out fossil fuels: learning from the injustice of adopting 1.5 °C over 1 °C

8. Rare T-Cell Subtypes

10. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

12. Rare T-Cell Subtypes

13. Going beyond carbon: An 'Earth system impact' score to better capture corporate and investment impacts on the earth system

14. CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre

15. Living within the safe and just Earth system boundaries for blue water

16. Update and new approaches in the treatment of Castleman disease

18. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

19. Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance

20. CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia

22. Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes

23. Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry

28. A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset ofNUTM1-rearranged tumors

29. Diagnosis, management and follow up of peripheral T cell lymphomas: A Consensus Practice Statement from the Australasian Lymphoma Alliance.

30. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses.

31. Identifying a Safe and Just Corridor for People and the Planet

32. SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence

33. Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target

34. Mycosis fungoides and Sezary syndrome: Australian clinical practice statement

35. Prognostic gene expression signature for high-grade serous ovarian cancer

39. Mycosis fungoides and Sezary syndrome: Australian clinical practice statement.

41. BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibition.

42. Increasing rates of SSA/P detection in a large open-access Australian colonoscopy cohort

43. Matching scope, purpose and uses of planetary boundaries science

45. A retrospective analysis of patients with co-existent mycosis fungoides and primary cutaneous anaplastic large cell lymphoma from the Australian Cutaneous Lymphoma Network database

47. Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.

48. Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

49. Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma.

50. Multi-level policies and adaptive social networks. A conceptual modeling study for maintaining a polycentric governance system

Catalog

Books, media, physical & digital resources